3,3',4,5'-tetrahydroxystilbene and ER-Negative PR-Negative HER2-Negative Breast Cancer

3,3',4,5'-tetrahydroxystilbene has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Darzynkiewicz, Z; Halicka, HD; Hsieh, TC; Lucas, J; Wu, JM	1

Other Studies

1 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling. International journal of oncology, 2018, Volume: 53, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; E1A-Associated p300 Protein; Female; G1 Phase Cell Cycle Checkpoints; Histone Deacetylases; Humans; NF-kappa B; Programmed Cell Death 1 Receptor; Resveratrol; Signal Transduction; Stilbenes; Treatment Outcome; Triple Negative Breast Neoplasms; Up-Regulation	2018

Article

Year

Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling.

International journal of oncology, 2018, Volume: 53, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; E1A-Associated p300 Protein; Female; G1 Phase Cell Cycle Checkpoints; Histone Deacetylases; Humans; NF-kappa B; Programmed Cell Death 1 Receptor; Resveratrol; Signal Transduction; Stilbenes; Treatment Outcome; Triple Negative Breast Neoplasms; Up-Regulation

2018